Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Journal of Blood Transfusion》 2014-04
Add to Favorite Get Latest Update

Evaluation on analysis function and operation performance of Procleix TIGRIS system at blood screening laboratory

YAO Fenglan;WANG Dehai;ZHA Wei;LENG Chan;WANG Zhongmei;YANG Haiping;ZHENG Jing;BAI Heqian;GE Hongwei;Blood Screening Laboratory,Beijing Red Cross Blood Center;  
Objective:To evaluate the analysis function and operation performance of Procleix TIGRIS System before Nucleic Acid Testing(NAT) which was implemented in blood screening laboratory;and to confirm the feasibility of Procleix TIGRIS System with the insurance of its efficient running that was under control.Methods We evaluated the the analysis function and operation performance of Procleix TIGRIS System,and we also compared the performance of different Procleix TIGRIS System.The WHO International Standards for HIV-1 RNA,HCV RNA,HBV DNA were used to determine the analysis sensitivity of the Procleix TIGRIS System.Severe hemolytic and midrange lipaemic blood samples with low-load of HIV,HCV and HBV virus was used to evaluate the Procleix TIGRIS System in the presence of endogenous,interfering substances,respectively.Samples containing high load of HBV( 106IU / ml) were used to evaluate the robustness of Procleix TIGRIS System against crosscontamination.The operation performance of Tigris System was evaluated from the throughput and stress test,the invalid work list and invalid run,and the stability of the assays.The performances of different Tigris Systems were compared by testing the same PT panels.Results 95% limits of detection(LODs) for HIV-1,HCV,HBV were 18.1 IU /mL(range from 12.2 ~ 36.9 IU /mL),7.4 IU /mL(range from 4.7 ~ 15.2 IU /mL),11.7 IU /mL(range from 7.6 ~ 22.5 IU /mL),respectively,for Procleix Ultrio Assay.And 16.3 IU /mL(range from 10.0 ~ 47.1IU /mL),5.8 IU /mL(range from 3.5 ~ 14.2 IU /mL),23.8 IU /mL(range from 13.0 ~ 61.6 IU /mL),respectively for Procleix Ultrio Discriminatory Assay on TIGRIS System.It was in coincidence with the analytic sensitivity provided by the manufacturer.No significant difference was observed between normal and severe hemolytic,midrange lipaemic blood samples for HIV(40 IU /mL),HCV(10 IU /mL),and HBV(20 IU /mL)on Procleix TIGRIS System.When Procleix TIGRIS System was challenged with no more than 10% positive samples( 106IU /mL) in a run,no cross-contamination was observed in negative samples;however,false-positive results owing to the aerosol could be found when the positive samples ratio increased to 20% or 50% in a run,but this aerosol did not truly contaminate the negative samples at all.Conclusion Procleix TIGRIS System was a fully automated NAT system with high sensitivity.The evaluation results of analysis function and operation performance of Procleix TIGRIS System before NAT implementation demonstrated our lab's capability on NAT.We also confirmed that hemolytic,lipaemic blood samples would not be an issue which might interfere to the NAT results significantly on Procleix TIGRIS System.Besides,there was no cross-contamination with no more than 10% positive samples in a run,which made NAT available to routine testing in our laboratory.The operation performance of Procleix TIGRIS System was very stable,and the homogenicity of different TIGRIS systems was high,and in accordant to the standards provided by the manufacture's instructions.
【Fund】: 卫生部卫生行业科研专项资助项目(201002005)
【CateGory Index】: R446.6
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Co-citations】
Chinese Journal Full-text Database 7 Hits
1 LV Meng'en;DONG Jie;WU Yaling;ZHU Hong;ZHU Faming;LV Hangjun;Blood Center of Zhejiang Province;Key Laboratory for Blood Safety Research,Ministry of Health;;Analysis of screening results by nucleic acid amplification testing in voluntary blood donors in Hangzhou,2011[J];Chinese Journal of Blood Transfusion;2014-01
2 ZHAO Xin;WANG Huan;LI Maosheng;LI Ying;GAO Jialiang;LI Wen;Chengdu Blood Center;;Application of real-time fluorimetry polymerase chain reaction to blood screening in Chengdu[J];Chinese Journal of Blood Transfusion;2014-01
3 YE Lian;ZHAO Zheng;WANG Fang;YANG Ping;Sichuan Science City Hospital;;Influencing factors on two-step ELISA detection of HBsAg[J];Laboratory Medicine and Clinic;2013-19
4 YAO Qing-qing;DONG Xiao-lian;WANG Xue-cai;XU Hai-tao;WANG Xiao-li;CHEN Sheng-yu;TANG Zhi-feng;ZHENG Ying-jie;Key Laboratory of Public Health Safety,Ministry of Education-Department of Epidemiology,School of Public Health,Fudan University;Deqing County Center for Disease Control and Prevention;;Prevalence of occult hepatitis B virus infection(OBI) and its phylogenetic analysis among a rural general population in Zhejiang Province,China[J];Fudan University Journal of Medical Sciences;2013-05
5 Francesco Vasuri;Deborah Malvi;Elisa Gruppioni;Walter F Grigioni;Antonia D'Errico-Grigioni;"F. Addarii" Institute of Oncology and Transplantation Pathology,S. Orsola-Malpighi Hospital,Bologna University,40138 Bologna,Italy;;Histopathological evaluation of recurrent hepatitis C after liver transplantation:A review[J];世界胃肠病学杂志(英文版);2014-11
6 Renumathy Dhanasekaran;Roberto J Firpi;Division of Gastroenterology and Hepatology,Mayo Clinic,Rochester,MN 55901,United States;Division of Gastroenterology,Hepatology and Nutrition,University of Florida,Gainesville,FL 32610,United States;;Challenges of recurrent hepatitis C in the liver transplant patient[J];世界胃肠病学杂志(英文版);2014-13
7 ZHANG Leilin;ZHANG Xuan;Guangzhou Blood Center;Guangdong Provincial Hospital of TCM;;Mechanism of Occult Hepatitis B Virus Infection and Its Effect on Blood Safety[J];Clinical Medicine & Engineering;2014-05
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved